Evidence map›Paper›PMID 36144412›Full record

ArticleMicroorganisms2022

Assessment of Lipopeptide Mixtures Produced by

Aline Leconte, Ludovic Tournant, Jérôme Muchembled, Jonathan Paucellier, Arnaud Héquet, Barbara Deracinois, Caroline Deweer, François Krier, Magali Deleu, Sandrine Oste and 2 more

Abstract read
In one paragraph

Article in Microorganisms, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Improving Surfactin Production inMicroorganisms · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Characterization ofMicroorganisms · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Aline LeconteUMRt BioEcoAgro 1158-INRAE, Equipe Métabolites Secondaires D'origine Microbienne, Institut Charles Viollette, Université de Lille, F-59000 Lille, France.
Ludovic TournantFREDON Hauts-de-France-265 rue Becquerel, F-62750 Loos-en-Gohelle, France.
Jérôme MuchembledJUNIA, UMRt BioEcoAgro 1158-INRAE, Equipe Métabolites Spécialisés D'origine Végétale, Institut Charles Viollette, F-59000 Lille, France.
Jonathan PaucellierUMRt BioEcoAgro 1158-INRAE, Equipe Métabolites Secondaires D'origine Microbienne, Institut Charles Viollette, Université de Lille, F-59000 Lille, France.
Arnaud HéquetLipofabrik SAS, 917 rue des Saules, F-59343 Lesquin, France.
Barbara DeracinoisUMRt BioEcoAgro 1158-INRAE, Equipe Métabolites Secondaires D'origine Microbienne, Institut Charles Viollette, Université de Lille, F-59000 Lille, France.ORCID 0000-0002-0279-2449
Caroline DeweerJUNIA, UMRt BioEcoAgro 1158-INRAE, Equipe Métabolites Spécialisés D'origine Végétale, Institut Charles Viollette, F-59000 Lille, France.ORCID 0000-0003-3576-9541
François KrierUMRt BioEcoAgro 1158-INRAE, Equipe Métabolites Secondaires D'origine Microbienne, Institut Charles Viollette, Université de Lille, F-59000 Lille, France.ORCID 0000-0002-2280-4662
Magali DeleuUMRt BioEcoAgro 1158-INRAE, Equipe Métabolites Secondaires D'origine Microbienne, TERRA Teaching and Research Centre, Gembloux Agro-Bio Tech, Université de Liège, B-5030 Gembloux, Belgium.ORCID 0000-0001-8255-2965
Sandrine OsteFREDON Hauts-de-France-265 rue Becquerel, F-62750 Loos-en-Gohelle, France.
Philippe JacquesUMRt BioEcoAgro 1158-INRAE, Equipe Métabolites Secondaires D'origine Microbienne, TERRA Teaching and Research Centre, Gembloux Agro-Bio Tech, Université de Liège, B-5030 Gembloux, Belgium.
François CoutteUMRt BioEcoAgro 1158-INRAE, Equipe Métabolites Secondaires D'origine Microbienne, Institut Charles Viollette, Université de Lille, F-59000 Lille, France.ORCID 0000-0002-5233-1181

Funding

European Regional Development Fund SmartBioControl ProgramHauts de France Region AgriBioPOMHauts de France Region AliBioTechSME Instrument H2020 849713
6 · The paper itself

Abstract

Apple scab is an important disease conventionally controlled by chemical fungicides, which should be replaced by more environmentally friendly alternatives. One of these alternatives could be the use of lipopeptides produced by

Indexed as

apple scabBacillus subtilisbiopesticidefengycinlipopeptidesmycosubtilinsurfactinVenturia inaequalis

Identifiers

PMID36144412
PMCPMC9501572

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.